However, given the effectiveness of TKIs in controlling the disease, BCR-ABL1 is potentially the major drive responsible for the abnormal proliferation of leukemia blasts in Ph+ALL. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.